The highest prevalence of carriers was found in TNBC cases (0.85%)—a subtype of BC aforementioned to be most likely to be associated with moderate risk in carriers of BARD1 variants—which is significantly higher than BC cases unselected for subtype (p < 0.001) (Figure 3, Table 4). Here, BARD1 is linked to breast cancer.